
Global Bioenergies has successfully completed the basic engineering phase of its plant project dedicated to the cosmetics markets whose commissioning is scheduled for mid-2027. The engineering work carried out as part of the basic engineering has precisely defined the each of the units that will enable the fully integrated production of cosmetic-grade isobutene derivatives. It also confirms the project schedule and the nominal CAPEX of 65 million euros (i.e. a maximum CAPEX of 80 million euros taking into account contingencies).






Bio-Botanica Inc., a family-owned and operated company, specializing in botanicals for over 45 years and headquartered in Hauppage (New York), has partnered with U.S. biotech company Genomatica to create a new line of botanical extracts using a naturally sourced, sustainably produced butylene glycol. These products, manufactured by Bio- Botanica Inc., feature Genomatica’s proprietary ingredient, Brontide.